National Plans for Rare Diseases The French plan Ségolène Aymé Orphanet On behalf of Alexandra Fourcade French Ministry of Health

Similar documents
AN OPPORTUNITY FOR PRIMARY CARE

EUCERD RECOMMENDATIONS QUALITY CRITERIA FOR CENTRES OF EXPERTISE FOR RARE DISEASES IN MEMBER STATES

European Haemophilia Consortium

National Strategies & Action for Rare Diseases in Europe

Lessons from the EMA Patient Registries Initiative

EJA: EUCERD Joint Action: working for rare diseases Glória Isidro

EUCERD RECOMMENDATIONS on RARE DISEASE EUROPEAN REFERENCE NETWORKS (RD ERNS)

Use of disease registries for benefitrisk evaluation of medicines: A regulatory perspective. DIA Europe April Basel, Switzerland

European Reference Networks (ERN) Guide for patient advocates

116 Help Lines for Rare Diseases

Member webinar: What is an ideal European Reference Network? Matt Johnson, EURORDIS 10 February 2016

VSOP, Lupus Netherlands

ERN Assessment Manual for Applicants

Patient Registries Initiative Background, Achievements, Next steps

VASCERN 1st Annual Seminar Paris, France October 2017

REFLECTION PROCESS on CHRONIC DISEASES INTERIM REPORT

European Reference Networks: strategic value for the Member States. Perspective of France

Compassionate Use Systems in the EU How to improve for early access to patients

Patient Registry Initiative- Strategy and Mandate of the Cross-Committee Task Force

Department of Medical Genetics, Medical School, University of Athens, Greece

Executive Report to the European Commission on newborn screening in the European Union

EUROPLAN National Conference organized by ACHSE in Germany 13 th and 14 th of October 2010 in Berlin CONFERENCE FINAL REPORT

High Level Pharmaceutical Forum

Council of the European Union Brussels, 8 September 2014 (OR. en) Mr Uwe CORSEPIUS, Secretary-General of the Council of the European Union

Study definition of CPD

Draft mandate Morbidity and Mortality Working Party

European Patients Academy on Therapeutic Innovation

European Quality Assurance Scheme for Breast Cancer Services

Resource on the State of the Art of Rare Disease Activities in Europe

NoRo - a reference centre for RD

Erasmus+ mid-term evaluation - the Swiss feedback 1 2 3

2013 REPORT ON THE STATE OF THE ART OF RARE DISEASE ACTIVITIES IN EUROPE

EARLY ACCESS IN BELGIUM: STATUS UPDATE. Veerle Kempeneers & Rudy De Cock - Pfizer Kristel De Gauquier pharma.be

Global challenges with European solutions: The fundamental role of EFIC

ERA-NET ERA-NET. Cooperation and coordination of national or regional research and innovation activities (i.e. programmes)

ERN board of Member States

Council of the European Union Brussels, 24 February 2015 (OR. en)

EUROPEAN JOINT PROGRAMME ON RARE DISEASES

***I DRAFT REPORT. EN United in diversity EN. European Parliament 2018/0018(COD)

TRAINING NEEDS FOR CPP MEMBERS IN FRANCE

DRAFT OPINION. EN United in diversity EN. European Parliament 2018/0018(COD) of the Committee on Industry, Research and Energy

Economic and Social Council

GIFT-MENA Governance Institutes Forum for Training. A regional partnership for knowledge-sharing on governance

- Proposal for a Regulation on HTA- DG SANTE - Health Systems and Products Medical Products: safety, quality, innovation

Dissemination and Communication Strategy Plan

State of the Art of Rare Disease - Activities in EU Member States and Other European Countries. Denmark Report

NICE Charter Who we are and what we do

A short paper for ENVI & IMCO MEPs Two solutions to improve recognition of specialisms in the Chapter III professions

Continuous Professional Development of Health Professionals European Context

European Patients Academy (EUPATI) Update

ECHA Helpdesk Support to National Helpdesks

NOTE BY THE TECHNICAL SECRETARIAT

Annual Work Programme 2018

EACEA Erasmus+ Sector Skills Alliances

UNIversal solutions in TELemedicine Deployment for European HEALTH care

European Reference Networks. Guidance on the recognition of Healthcare Providers and UK Oversight of Applications

G-I-N 2016 conference report

Suggestions for Modification of the Clinical Trials Directive ELN Annual Meeting 01 February 2011

ERN-EYE Kick-Off Meeting brief report

Developing a European Registry for Rare Anaemias

4. Multi Stakeholder: Late & Early Dialogue

biopsie chez l enfant

Statistical Analysis of the EPIRARE Survey on Registries Data Elements

EUROPLAN National Conferences CONFERENCE FINAL REPORT. I. General information

The German Institute of Medical Documentation and Information

Policies contributing to Health Reforms leading to improved management of Rare Diseases/ Anaemias/ Haemoglobin Disorders in Europe

During the one session on value based assessment (VBA), the audience heard from 3 speakers:

Vertex Investigator-Initiated Studies Program Overview

RED CELL PATHOLOGY UNIT. HOSPITAL CLINIC-UNIVERSITY OF BARCELONA, Spain

Pharmacovigilance: The patient s Perspective. Souzi Makri Chairperson AGORA EUPATI Fellow Executive Secretary CYPLAR President ENFA

EPF Workshops on Cross-Border Healthcare 1st Stop: Croatia Meeting Report

Innovation Voucher Frequently Asked Questions: April 2017 INNOVATION VOUCHERS FREQUENTLY ASKED QUESTIONS

Medical Device Reimbursement in the EU, current environment and trends. Paula Wittels Programme Director

2014 REPORT ON THE STATE OF THE ART OF RARE DISEASE ACTIVITIES IN EUROPE

Horizon Health

JOINT DECLARATION ON THE PROMOTION AND THE ENFORCEMENT OF CANCER PATIENTS RIGHTS

III. The provider of support is the Technology Agency of the Czech Republic (hereafter just TA CR ) seated in Prague 6, Evropska 2589/33b.

Ministry of Education, Universities and Research

Proposal for a new legal framework for data protection in EU

The following passage wants to illustrate the insufficiencies in CF care the patients, their families and care giver struggle with:

CALL FICHE 1 SCIENCE IN SOCIETY 2009

ICH Regulators Forum. Dr Peter Arlett EU

PRE-ANNOUNCEMENT OF CALL FOR PROPOSALS IN 2013

Meeting report series. Report of the 2nd Funders Constituent Committee Meeting

Value Added Medicines Rethink, Reinvent & Optimize Medicines, Improving Patient Health & Access

ITALY SLOVENIA JOINT SCIENCE AND TECHNOLOGY COOPERATION CALL FOR JOINT PROJECT PROPOSALS. CLOSING DATE: 15 th February 2018

Toolbox for the collection and use of OSH data

Confronting the Challenges of Rare Disease:

Societal Challenge 1: Health, demographic change & wellbeing Bucharest - Romania Dr Cristina Pascual National Documentation Centre - EKT

Version Number: 003. On: September 2017 Review Date: September 2020 Distribution: Essential Reading for: Information for: Page 1 of 13

Newborn Screening Programmes in the United Kingdom

Terms of Reference for the Recruitment of a Trainer

2nd European Reference Networks Conference 8-9 October Lisbon, Portugal. A report by: G Porto & F Courtois

Erasmus MC, Center for lysosomal and metabolic diseases, Netherlands

PAED-Net the German Network

HTA and Patient Registries. Fedele (Duccio) Bonifazi

Central Manchester University Hospitals NHS Foundation Trust, UK

Deadline extended to Friday, June 1, 2018 Competitive Grant Program in Migraine Research

EU measures to support RTD and innovation activities performed by SMEs

Meeting report series. Report of the 16th Therapies Scientific Committee Meeting

Transcription:

National Plans for Rare Diseases The French plan 2005-2008 2008 Ségolène Aymé Orphanet On behalf of Alexandra Fourcade French Ministry of Health

Political Context Public Health Law of 9 August 2004 100 defined targets Rare Diseases among the 5 Top Priorities Previous initiatives: Orphan Drug Office established in 1995 Orphanet established in 1996 Eurordis launched in 1997 Rare Disease Platform established in 2001

Ten strategic priorities and 100 Millions Euros 1- Increase knowledge of the epidemiology of RD 2- Recognise the specificity of RD 3- Develop information for all stakeholders 4- Train professionals 5- Organise screening and access to diagnostic tests 6- Improve access to treatment and healthcare provision 7- Continue effort in favour of Orphan Drugs 8- Respond to social needs and support patients organisations 9- Promote research and innovation 10- Develop national and European partnership

Achievements: Epidemiology In the field of registries Establishment of a national committee in charge of registries for rare diseases Joint call for proposals (public health + research) Designation of registries but without funding In the field of information systems Obligation for the centres of reference to collect clinical data on all rare diseases seen at their centre Budget allocated to this activity No harmonisation of systems (3 main tools) Tools developed by Orphanet

Achievements:Specificity of RD Development of national protocols for diagnosis and care by the HTA agency (HAS) Reimbursement of drugs and devices with no official indication for RD, or outside the usual reimbursement scope (on request of centres of reference or patients organisations) Reimbursement of transport costs to attend clinics at centres of reference Establishment of a RD office at the national health insurance agency to deal with all problems and jharmonise practices in the regions

Achievements: Information New services at Orphanet Encyclopaedia for patients in French Emergency guidelines Search by sign facility Introduction of classifications to improve search facility Portal accessible to disabled Publication of a book distributed to 10 000 professionals Emergency cards Produced by the Ministry / distributed by the centres of reference Support to Helpline

Achievements: Training Introduction of two hours in the cursus of medical students: existence of RD + how to access relevant information Optional modules for medical students 30 hours course Similar measures for non MD health professionals

Achievements: Screening/Testing Screening Nothing done for political reasons Project: establish a committee to assess population screening proposals and review outcomes Testing To improve availability of diagnostic tests Organisation of networks of laboratories (oncogenetics, neurogenetics, mental retardation, neurosensory genetics ) Reference laboratories Funding of testing activities (20 Millions)

Achievements: Healthcare provision Establishment of centres of reference Establishment of a national committee Through annual call for proposals National coverage / based on scientific expertise + volume of activity + real 5 year plan to improve care 132 centres approved and funded (over 100 M Euros already) 200 new positions for MD + 200 new positions for non MDs: permanent Mission of expertise, information, training and research / self assessment at 3 years / external assessment at 5 years Establishment of centres of competence At the request of patients organisations At regional level Network common to several centres of reference sometimes

Achievements: Support orphan drugs Preservation of existing situation Exemption for the promoters of OD with respect to taxes and payments due OD on the list of innovative and expensive health products to be systematically covered Prevention of unavailability of marketed OD «Autorisation temporaire d utilisation» scheme to be continued

Achievements: Social needs Coordination between Plan for Rare Diseases and Plan for Disabled people: recognition of the additional burden attached to RD Publication of a brochure on rights and opportunities for patients with RD By Orphanet Available on the frontpage of the website Included in the encyclopaedia for the patients Distribution of the Orphanet book to all institutions for disabled

Achievements: Promotion of Research Annual call for proposals for preclinical research GIS-Institut des maladies rares Networks, registries, platforms and all types of research projects 30 M Euros Annual call for proposals for clinical research For hospital-based teams Academic trials and clinical research in general 26 M Euros Annual joint call with some othe EU countries E-Rare: 9 M Euros first year (2.4 from France)

Achievements: Partnerships National coordination of all partners Follow-up committee Support to the Rare Diseases Platform in Paris GIS maladies rares- Orphanet Alliance Maladies Rares Eurordis Helpline Hosting of 200 meetings per year Communication Contribute to European policy Orphanet in 38 countries Rare Diseases Task Force secretariat Eurordis Proactive Ministry of Health / contribution to the EC Communication

CONCLUSION Assessment of the national plan : High level Public Health Committee December 2008 Difficult to document yet the objective effects Very positive feeling of stakeholders Support of ongoing initiatives in the future Lessons to be learned